_id
690dab97ccc777a4e85d0936
Ticker
AHCO
Name
Adapthealth Corp
Exchange
NASDAQ
Address
220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://adapthealth.com
Description
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Last Close
10.29
Volume
1176228
Current Price
10.25
Change
-0.388726919339156
Last Updated
2025-11-28T11:59:10.721Z
Image
data:image/webp;base64,UklGRowEAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSBACAAANkCPbtmora+9zv+HukLtDAyj64G6xhZ6SkhFZO6ADmrm7uz65Z6/gnrO5710sjIgJwP91ybEpzDVVR5iQ2GqE2vwzXQFgww/2fRH2HzB+blBU9U4HjSwLYyWUiqYGJENszL+5aCYGh1roI1oG30dnLCLWEjwxp7ZiR1sqLN9BKoLp+4PWEj1OtYVrCxEAGERu3OYxkBqG1o2OUmH4fCFmgNZwJJISkC1Ro3DyybGSwqPDpTAjKPDLEuoACEFWSTSTKSGaKikI2ARBzZSYEc3Q6iGkngIh4xStp2bi48Mfwkoct5wCgPL52iBrkVoiLp4YDp0C5cjXJacybw49HwidAbNfodQBdLvoogTaaA8hrT8QS3QBIDhiEZEXoeZgSFORJSBIRwd+DoZcKTCHk5IBwMxaR7R3kIRg8lLTFAeeX8/Ve9FRRDrmnh6BJCIuHRWwB+4AJwVONfSUHohD6BDCawk1cYjLLQ63QhMItFx/t74oK8OtsWii4fquYQOgrXkAGwB0n7dQNTRWkTWHudRBMKf0WM6rLq9AcuhCLFPrYweLmSFF+fSFqbIYJ6CwB2tyUk4/P8U09WL9z8DKUPw4HkQv3+SAcnJANr6HoRpB9FgcDAanUBJV9oYOUDwEHf/RKZZSk2YoNIXB0ppgL7VkYujbAPqfeL/r9UBCurMB9h1Qvo5Il2ioIk82wxz/UwFWUDggVgIAAJAOAJ0BKkAAQAA+pUKYSaYjoiE59O1QwBSJbAJgAgAD8ALOhtt4EW9cP2XfjrPba/zAfqf+uXu3egDyYOtE9AD9QPTW9jb9x/3A9qpPAe615K0I5R9BbRBKM02U1NdiOcHVTXpuoSZaDPg2RfD+DXwkVqdgKbsXsFn+W0Q+AP78XNKv9fKMqkvJ51nHCtV57XGlDvve7G3Sg9sM+esn8gBb/D0lglSjIA/SXf/xOHtBuZPSpzqUeT+TBsJvHfwPfg7ZVLy8EYP/x63+RRBUZs/RW//91h+D8VS02LKn5RW/4IZ8/EdS32WlZ6S8alnv7V+FhVy+Ty2Wf3tIAi9ngGfNbwQBmJrEUw/7FbOSija+HqOfrNN4b3Q9RsVYwJempGYB1rCfzUhobB0nhkixqTNLLKeuyINhbcYxDdFchXHUscu6j70mVVZIlFjnDjZrHYrYuKWJ/ZssJmCXJ5eVglwhMSth+B3Z184JGpi5j/MZZB8RwwPnib73v5nS83BX/b0pjLQB8cy6MBMbzlGsD1oHXUztk4vahsAXcPPbZC38MPPE8Z9sfRC89a+Ykt7wx4uNPRvQB45YeY4Pn/UYuOZc6h/JNGNlHnHWOww9SDz+/43fT2244xS4Xb/KDBx/H6cuiD7v//4IHyMWPLplfXGtrRI+D6cioEec0d88yB38nBM4f9AcgKZnbvrgem0bmkKMQOvo/86X35rsP201YIXPRwCslyr7q7X2q1VMnDL4ucLbb/n2FcXkyMc5W9+1sZdmCYJlivGxT/pMo9myd4W/aQAAAAA=
Ipo Date
2018-05-24T00:00:00.000Z
Market Cap
1301427840
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9941428571428571
Sentiment Sources
7
Rating
4.375
Target Price
13.25
Strong Buy
5
Buy
1
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
820314000
Cost Of Revenue
668473000
Gross Profit
151841000
Operating Expenses
85911000
Operating Income
65930000
Interest Expense
25380000
Pretax Income
36350000
Net Income
22451000
Eps
0.1636239077041928
Dividends Per Share
-
Shares Outstanding
135424334
Income Tax Expense
10600000
EBITDA
170938000
Operating Margin
8.03716625584837
Total Other Income Expense Net
-29580000
Cash
80357000
Short Term Investments
-
Receivables
412519000
Inventories
149092000
Total Current Assets
724824000
Property Plant Equipment
628564000
Total Assets
4383523000
Payables
341450000
Short Term Debt
60136000
Long Term Debt
1743930000
Total Liabilities
2758672000
Equity
1616782000
Depreciation
109208000
Change In Working Capital
-18059000
Cash From Operations
161066000
Capital Expenditures
94242000
Cash From Investing
-92741000
Cash From Financing
-56598000
Net Change In Cash
11727000
PE
17.4727
PB
0.8732786423896356
ROE
1.388622584863018
ROA
0.5121679525806069
FCF
66824000
Fcf Percent
0.08146148913708653
Piotroski FScore
4
Health Score
48
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
7.5
Growth Investing Score
7
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
820314000
Quarters > 0 > income Statement > cost Of Revenue
668473000
Quarters > 0 > income Statement > gross Profit
151841000
Quarters > 0 > income Statement > operating Expenses
85911000
Quarters > 0 > income Statement > operating Income
65930000
Quarters > 0 > income Statement > interest Expense
25380000
Quarters > 0 > income Statement > pretax Income
36350000
Quarters > 0 > income Statement > net Income
22451000
Quarters > 0 > income Statement > eps
0.1636239077041928
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
137211000
Quarters > 0 > income Statement > income Tax Expense
10600000
Quarters > 0 > income Statement > EBITDA
170938000
Quarters > 0 > income Statement > operating Margin
8.03716625584837
Quarters > 0 > income Statement > total Other Income Expense Net
-29580000
Quarters > 0 > balance Sheet > cash
80357000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
412519000
Quarters > 0 > balance Sheet > inventories
149092000
Quarters > 0 > balance Sheet > total Current Assets
724824000
Quarters > 0 > balance Sheet > property Plant Equipment
628564000
Quarters > 0 > balance Sheet > total Assets
4383523000
Quarters > 0 > balance Sheet > payables
341450000
Quarters > 0 > balance Sheet > short Term Debt
60136000
Quarters > 0 > balance Sheet > long Term Debt
1743930000
Quarters > 0 > balance Sheet > total Liabilities
2758672000
Quarters > 0 > balance Sheet > equity
1616782000
Quarters > 0 > cash Flow > net Income
22451000
Quarters > 0 > cash Flow > depreciation
109208000
Quarters > 0 > cash Flow > change In Working Capital
-18059000
Quarters > 0 > cash Flow > cash From Operations
161066000
Quarters > 0 > cash Flow > capital Expenditures
94242000
Quarters > 0 > cash Flow > cash From Investing
-92741000
Quarters > 0 > cash Flow > cash From Financing
-56598000
Quarters > 0 > cash Flow > net Change In Cash
11727000
Quarters > 0 > ratios > PE
0.1636239077041928
Quarters > 0 > ratios > PB
0.8732786423896356
Quarters > 0 > ratios > ROE
1.388622584863018
Quarters > 0 > ratios > ROA
0.5121679525806069
Quarters > 0 > ratios > FCF
66824000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.08146148913708653
Quarters > 0 > health Score
48
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
591811000
Quarters > 1 > income Statement > cost Of Revenue
645714000
Quarters > 1 > income Statement > gross Profit
-53903000
Quarters > 1 > income Statement > operating Expenses
-133155000
Quarters > 1 > income Statement > operating Income
79252000
Quarters > 1 > income Statement > interest Expense
27533000
Quarters > 1 > income Statement > pretax Income
51719000
Quarters > 1 > income Statement > net Income
14674000
Quarters > 1 > income Statement > eps
0.10705400850654041
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
137071000
Quarters > 1 > income Statement > income Tax Expense
35891000
Quarters > 1 > income Statement > EBITDA
171612000
Quarters > 1 > income Statement > operating Margin
13.391437469056843
Quarters > 1 > income Statement > total Other Income Expense Net
-27533000
Quarters > 1 > balance Sheet > cash
68630000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
393593000
Quarters > 1 > balance Sheet > inventories
148852000
Quarters > 1 > balance Sheet > total Current Assets
658001000
Quarters > 1 > balance Sheet > property Plant Equipment
625518000
Quarters > 1 > balance Sheet > total Assets
4350825000
Quarters > 1 > balance Sheet > payables
339654000
Quarters > 1 > balance Sheet > short Term Debt
59694000
Quarters > 1 > balance Sheet > long Term Debt
1792741000
Quarters > 1 > balance Sheet > total Liabilities
2756699000
Quarters > 1 > balance Sheet > equity
1587444000
Quarters > 1 > cash Flow > net Income
15828000
Quarters > 1 > cash Flow > depreciation
92360000
Quarters > 1 > cash Flow > change In Working Capital
53127000
Quarters > 1 > cash Flow > cash From Operations
161994000
Quarters > 1 > cash Flow > capital Expenditures
88665000
Quarters > 1 > cash Flow > cash From Investing
9604000
Quarters > 1 > cash Flow > cash From Financing
-156618000
Quarters > 1 > cash Flow > net Change In Cash
14980000
Quarters > 1 > ratios > PE
0.10705400850654041
Quarters > 1 > ratios > PB
0.8885104545420185
Quarters > 1 > ratios > ROE
0.9243790647103142
Quarters > 1 > ratios > ROA
0.33726936845310945
Quarters > 1 > ratios > FCF
73329000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.12390611191748717
Quarters > 1 > health Score
52
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
580471000
Quarters > 2 > income Statement > cost Of Revenue
657444000
Quarters > 2 > income Statement > gross Profit
-76973000
Quarters > 2 > income Statement > operating Expenses
-100143000
Quarters > 2 > income Statement > operating Income
23170000
Quarters > 2 > income Statement > interest Expense
28399000
Quarters > 2 > income Statement > pretax Income
-5229000
Quarters > 2 > income Statement > net Income
-7207000
Quarters > 2 > income Statement > eps
-0.05346478831445337
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
134799000
Quarters > 2 > income Statement > income Tax Expense
850000
Quarters > 2 > income Statement > EBITDA
117515000
Quarters > 2 > income Statement > operating Margin
3.991586142976996
Quarters > 2 > income Statement > total Other Income Expense Net
-28399000
Quarters > 2 > balance Sheet > cash
53650000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
418455000
Quarters > 2 > balance Sheet > inventories
129295000
Quarters > 2 > balance Sheet > total Current Assets
745173000
Quarters > 2 > balance Sheet > property Plant Equipment
622436000
Quarters > 2 > balance Sheet > total Assets
4437350000
Quarters > 2 > balance Sheet > payables
294331000
Quarters > 2 > balance Sheet > short Term Debt
60891000
Quarters > 2 > balance Sheet > long Term Debt
1941062000
Quarters > 2 > balance Sheet > total Liabilities
2863496000
Quarters > 2 > balance Sheet > equity
1567799000
Quarters > 2 > cash Flow > net Income
-6079000
Quarters > 2 > cash Flow > depreciation
94345000
Quarters > 2 > cash Flow > change In Working Capital
-9406000
Quarters > 2 > cash Flow > cash From Operations
95527000
Quarters > 2 > cash Flow > capital Expenditures
95585000
Quarters > 2 > cash Flow > cash From Investing
-95585000
Quarters > 2 > cash Flow > cash From Financing
-56039000
Quarters > 2 > cash Flow > net Change In Cash
-56097000
Quarters > 2 > ratios > PE
-0.05346478831445337
Quarters > 2 > ratios > PB
0.884731850192531
Quarters > 2 > ratios > ROE
-0.45968902901456116
Quarters > 2 > ratios > ROA
-0.16241675774955774
Quarters > 2 > ratios > FCF
-58000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.00009991885899553983
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
856645000
Quarters > 3 > income Statement > cost Of Revenue
528777000
Quarters > 3 > income Statement > gross Profit
327868000
Quarters > 3 > income Statement > operating Expenses
230201000
Quarters > 3 > income Statement > operating Income
97667000
Quarters > 3 > income Statement > interest Expense
29729000
Quarters > 3 > income Statement > pretax Income
70711000
Quarters > 3 > income Statement > net Income
50262000
Quarters > 3 > income Statement > eps
0.36812808531208346
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
136534000
Quarters > 3 > income Statement > income Tax Expense
19308000
Quarters > 3 > income Statement > EBITDA
190977000
Quarters > 3 > income Statement > operating Margin
11.401105475430311
Quarters > 3 > income Statement > total Other Income Expense Net
-26956000
Quarters > 3 > balance Sheet > cash
109747000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
408019000
Quarters > 3 > balance Sheet > inventories
139842000
Quarters > 3 > balance Sheet > total Current Assets
755788000
Quarters > 3 > balance Sheet > property Plant Equipment
618356000
Quarters > 3 > balance Sheet > total Assets
4486947000
Quarters > 3 > balance Sheet > payables
284602000
Quarters > 3 > balance Sheet > short Term Debt
60510000
Quarters > 3 > balance Sheet > long Term Debt
1964921000
Quarters > 3 > balance Sheet > total Liabilities
2908829000
Quarters > 3 > balance Sheet > equity
1571145000
Quarters > 3 > cash Flow > net Income
51403000
Quarters > 3 > cash Flow > depreciation
90537000
Quarters > 3 > cash Flow > change In Working Capital
-21052000
Quarters > 3 > cash Flow > cash From Operations
150415000
Quarters > 3 > cash Flow > capital Expenditures
77336000
Quarters > 3 > cash Flow > cash From Investing
-86872000
Quarters > 3 > cash Flow > cash From Financing
-53976000
Quarters > 3 > cash Flow > net Change In Cash
9567000
Quarters > 3 > ratios > PE
0.36812808531208346
Quarters > 3 > ratios > PB
0.8942108207708391
Quarters > 3 > ratios > ROE
3.1990681954880045
Quarters > 3 > ratios > ROA
1.1201826096898404
Quarters > 3 > ratios > FCF
73079000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.08530838328595859
Quarters > 3 > health Score
50
Valuation > metrics > PE
17.4727
Valuation > metrics > PB
0.8732786423896356
Valuation > final Score
100
Valuation > verdict
6.3% Undervalued
Profitability > metrics > ROE
1.388622584863018
Profitability > metrics > ROA
3.097441585819454
Profitability > metrics > Net Margin
0.027368788049454234
Profitability > final Score
16
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.7062733256555305
Risk > metrics > Interest Coverage
2.5977147360126085
Risk > final Score
40
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.804903557394929
Liquidity > metrics > Quick Ratio
1.4336455952149727
Liquidity > final Score
95
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
12
Prev Profitabilities > 1
0
Prev Profitabilities > 2
35
Prev Risks > 0
42
Prev Risks > 1
33
Prev Risks > 2
43
Prev Liquidities > 0
91
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T13:30:22.099Z
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Big Picture: How AHCO stock performs in stagflation - Market Growth Report & Free Weekly Chart Analysis and Trade Guides moha.gov.vn
Read more →AdaptHealth Corp. (NASDAQ:AHCO) Given Consensus Recommendation of “Hold” by Brokerages Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$13.25
Analyst Picks
Strong Buy
5
Buy
1
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 77.18% of the total shares of Adapthealth Corp
1.
BlackRock Inc(11.174%)
since
2025/06/30
2.
OEP CAPITAL ADVISORS, L.P.(10.2132%)
since
2025/06/30
3.
Vanguard Group Inc(8.7611%)
since
2025/06/30
4.
Deerfield Management Co(7.3208%)
since
2025/06/30
5.
FMR Inc(6.637%)
since
2025/06/30
6.
Reinhart Mahoney Capital Management Inc(5.4048%)
since
2025/06/30
7.
Dimensional Fund Advisors, Inc.(3.8231%)
since
2025/06/30
8.
Jefferies Financial Group Inc(3.5329%)
since
2025/06/30
9.
Segall Bryant & Hamill(3.4608%)
since
2025/06/30
10.
State Street Corp(3.2235%)
since
2025/06/30
11.
Palisade Capital Management LLc(1.9459%)
since
2025/06/30
12.
Geode Capital Management, LLC(1.8203%)
since
2025/06/30
13.
Principal Financial Group Inc(1.8081%)
since
2025/06/30
14.
Iron Triangle Partners LP(1.4191%)
since
2025/06/30
15.
Amvescap Plc.(1.4088%)
since
2025/06/30
16.
Royal Bank of Canada(1.3613%)
since
2025/06/30
17.
Charles Schwab Investment Management Inc(1.1547%)
since
2025/06/30
18.
Kennedy Capital Management Inc(1.0381%)
since
2025/06/30
19.
Bridgeway Capital Management, LLC(0.8443%)
since
2025/06/30
20.
Ameriprise Financial Inc(0.8306%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.